We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
1301
Charles River Laboratories
CRL
$10.9B
$335K ﹤0.01%
2,360
+26
+1% +$3.53K
HEI.A icon
1302
HEICO Corp Class A
HEI.A
$35.4B
$335K ﹤0.01%
3,238
+135
+4% +$12.4K
VWOB icon
1303
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$335K ﹤0.01%
+4,168
New +$326K
TKR icon
1304
Timken Company
TKR
$9.82B
$334K ﹤0.01%
6,503
-75
-1% -$3.58K
TRN icon
1305
Trinity Industries
TRN
$2.97B
$334K ﹤0.01%
16,073
-1,603
-9% -$34.1K
BANX
1306
ArrowMark Financial
BANX
$190M
$333K ﹤0.01%
15,266
-949
-6% -$20.6K
VKTX icon
1307
Viking Therapeutics
VKTX
$4.04B
$333K ﹤0.01%
40,112
+1,012
+3% +$8.65K
IGM icon
1308
iShares Expanded Tech Sector ETF
IGM
$9.94B
$332K ﹤0.01%
9,222
-234
-2% -$8.27K
MDU icon
1309
MDU Resources
MDU
$4.44B
$332K ﹤0.01%
33,799
-2,843
-8% -$27.7K
SNPS icon
1310
Synopsys
SNPS
$71.5B
$332K ﹤0.01%
2,579
+505
+24% +$60.7K
DBRG icon
1311
DigitalBridge
DBRG
$2.94B
$331K ﹤0.01%
16,534
-315
-2% -$6.53K
NKTR icon
1312
Nektar Therapeutics
NKTR
$2.39B
$331K ﹤0.01%
619
-101
-14% -$50.6K
SLF icon
1313
Sun Life Financial
SLF
$45.6B
$331K ﹤0.01%
8,010
+553
+7% +$22.2K
HTD
1314
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$924M
$330K ﹤0.01%
13,000
+1,200
+10% +$29.9K
NMFC icon
1315
New Mountain Finance
NMFC
$646M
$328K ﹤0.01%
23,513
-6,819
-22% -$95.3K
ARR
1316
Armour Residential REIT
ARR
$2.02B
$327K ﹤0.01%
3,506
+92
+3% +$8.65K
CDW icon
1317
CDW
CDW
$17.1B
$327K ﹤0.01%
2,946
+130
+5% +$13.6K
CSII
1318
DELISTED
Cardiovascular Systems, Inc.
CSII
$326K ﹤0.01%
+7,604
New +$295K
PFM icon
1319
Invesco Dividend Achievers ETF
PFM
$788M
$325K ﹤0.01%
11,324
XLC icon
1320
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$325K ﹤0.01%
+6,605
New +$321K
DORM icon
1321
Dorman Products
DORM
$4.01B
$324K ﹤0.01%
3,719
-24
-0.6% -$2.08K
MRTX
1322
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$324K ﹤0.01%
3,150
FXH icon
1323
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
$323K ﹤0.01%
4,166
GATX icon
1324
GATX Corp
GATX
$6.55B
$323K ﹤0.01%
4,074
+985
+32% +$74.9K
QYLD icon
1325
Global X NASDAQ-100 Covered Call ETF
QYLD
$7.97B
$323K ﹤0.01%
14,158
+477
+3% +$10.8K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.